The 73 rating InvestorsObserver gives to Jazz Pharmaceuticals PLC (JAZZ) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 96 percent of stocks in the Biotechnology industry, JAZZ’s 73 overall rating means the stock scores better than 73 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
Does Jazz Pharmaceuticals PLC (JAZZ) Have What it Takes to be in Your Portfolio Monday?
JAZZ has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on JAZZ!